These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 31531779

  • 1. Significant risk of occult cancer in complex non-atypical endometrial hyperplasia.
    Travaglino A, Raffone A, Saccone G, D'Alessandro P, Arduino B, de Placido G, Mascolo M, Insabato L, Zullo F.
    Arch Gynecol Obstet; 2019 Nov; 300(5):1147-1154. PubMed ID: 31531779
    [Abstract] [Full Text] [Related]

  • 2. Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia.
    Travaglino A, Raffone A, Saccone G, Mollo A, De Placido G, Mascolo M, Insabato L, Zullo F.
    APMIS; 2019 Jun; 127(6):427-434. PubMed ID: 30802329
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer.
    Raffone A, Travaglino A, Saccone G, Cieri M, Mascolo M, Mollo A, Insabato L, Zullo F.
    APMIS; 2019 Sep; 127(9):597-606. PubMed ID: 31237034
    [Abstract] [Full Text] [Related]

  • 4. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
    Sanderson PA, Critchley HO, Williams AR, Arends MJ, Saunders PT.
    Hum Reprod Update; 2017 Mar 01; 23(2):232-254. PubMed ID: 27920066
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
    Travaglino A, Raffone A, Saccone G, Mascolo M, D'Alessandro P, Arduino B, Mollo A, Insabato L, Zullo F.
    APMIS; 2019 Nov 01; 127(11):699-709. PubMed ID: 31403731
    [Abstract] [Full Text] [Related]

  • 8. Diabetes Mellitus Is Associated with Occult Cancer in Endometrial Hyperplasia.
    Raffone A, Travaglino A, Saccone G, D'Alessandro P, Arduino B, Mascolo M, De Placido G, Insabato L, Zullo F.
    Pathol Oncol Res; 2020 Jul 01; 26(3):1377-1384. PubMed ID: 31203571
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis.
    Raffone A, Travaglino A, Saccone G, Viggiani M, Giampaolino P, Insabato L, Mollo A, De Placido G, Zullo F.
    Arch Gynecol Obstet; 2019 Jun 01; 299(6):1511-1524. PubMed ID: 30915635
    [Abstract] [Full Text] [Related]

  • 11. Endometrial hyperplasia as a risk factor of endometrial cancer.
    Nees LK, Heublein S, Steinmacher S, Juhasz-Böss I, Brucker S, Tempfer CB, Wallwiener M.
    Arch Gynecol Obstet; 2022 Aug 01; 306(2):407-421. PubMed ID: 35001185
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
    Yang YF, Liao YY, Peng NF, Li LQ, Xie SR, Wang RB.
    Pathol Res Pract; 2012 Dec 15; 208(12):708-12. PubMed ID: 23044462
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
    Ip PP, Irving JA, McCluggage WG, Clement PB, Young RH.
    Am J Surg Pathol; 2013 Feb 15; 37(2):167-77. PubMed ID: 23211295
    [Abstract] [Full Text] [Related]

  • 19. Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis.
    Raffone A, Travaglino A, Saccone G, Mollo A, De Placido G, Insabato L, Zullo F.
    Acta Obstet Gynecol Scand; 2019 Aug 15; 98(8):976-987. PubMed ID: 30779338
    [Abstract] [Full Text] [Related]

  • 20. Comparison of endometrial cancer risk in patients with endometrial precancerous lesions: WHO 1994 vs EIN classification.
    Kender Erturk N, Basaran D, Salman C.
    J Obstet Gynaecol; 2022 May 15; 42(4):692-695. PubMed ID: 34415826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.